Regency Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17M | Sell |
7,829
-2,145
| -22% | -$870K | 1.67% | 22 |
|
|
2025
Q1 | $4.96M | Buy |
9,974
+2,860
| +40% | +$1.42M | 2.97% | 13 |
|
|
2024
Q4 | $3.7M | Buy |
+7,114
| New | +$3.7M | 2% | 22 |
|
|
2024
Q1 | – | Sell |
-4,571
| Closed | -$2.43M | – | 57 |
|
|
2023
Q4 | $2.43M | Sell |
4,571
-109
| -2% | -$57.9K | 1.63% | 25 |
|
|
2023
Q3 | $2.37M | Sell |
4,680
-362
| -7% | -$183K | 2.01% | 18 |
|
|
2023
Q2 | $2.63M | Buy |
5,042
+79
| +2% | +$41.2K | 2.29% | 15 |
|
|
2023
Q1 | $2.86M | Sell |
4,963
-337
| -6% | -$194K | 3.46% | 11 |
|
|
2022
Q4 | $2.92M | Sell |
5,300
-151
| -3% | -$83.2K | 3.35% | 12 |
|
|
2022
Q3 | $2.77M | Sell |
5,451
-84
| -2% | -$42.6K | 3.39% | 12 |
|
|
2022
Q2 | $3.01M | Sell |
5,535
-1,929
| -26% | -$1.05M | 3.23% | 15 |
|
|
2022
Q1 | $4.41M | Buy |
7,464
+341
| +5% | +$201K | 3.2% | 9 |
|
|
2021
Q4 | $4.75M | Buy |
7,123
+1,700
| +31% | +$1.13M | 3.02% | 10 |
|
|
2021
Q3 | $3.1M | Buy |
5,423
+183
| +3% | +$105K | 2.18% | 14 |
|
|
2021
Q2 | $2.64M | Buy |
5,240
+1,617
| +45% | +$816K | 2% | 14 |
|
|
2021
Q1 | $1.65M | Buy |
+3,623
| New | +$1.65M | 1.74% | 19 |
|